Joseph Bailes
Direttore/Membro del Consiglio presso TerSera Therapeutics LLC
Provenienza dei contatti di primo grado di Joseph Bailes
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 23 | |
TerSera Therapeutics LLC
 TerSera Therapeutics LLC Pharmaceuticals: MajorHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL.
5
| Holding Company | Pharmaceuticals: Major | 5 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.
4
| Non-Profit Organization | Medical/Nursing Services | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Joseph Bailes tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Actient Pharmaceuticals LLC
 Actient Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Actient Pharmaceuticals LLC develops and markets pharmaceutical therapeutic products. The company was founded in March 2009 and is headquartered in Malvern, VA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Crealta Pharmaceuticals LLC
 Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
GTCR LLC
 GTCR LLC Investment ManagersFinance GTCR LLC (GTCR) is a private equity firm founded in 1980 by Charlie Thomas. The firm is headquartered in Chicago, Illinois. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| ALBANY MOLECULAR RESEARCH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Corza Health, Inc.
 Corza Health, Inc. Packaged SoftwareTechnology Services Corza Health, Inc. develops healthcare platform for life sciences and medical technology sectors. The company was founded in 2019 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member Director/Board Member | |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Cole-Parmer Instrument Co. LLC
 Cole-Parmer Instrument Co. LLC Medical SpecialtiesHealth Technology Antylia Scientific provides laboratory and industrial fluid handling products, instrumentation, equipment, and supplies. The firm's services include calibration services, custom-blend chemicals, custom cut-to-lenght tubing, custom single-use bioprocess assemblies, custom temperature probes, on-site calibration services and special and custom orders. The company was founded by Jerry Cole and John Parmer in January 1955 and is headquartered in Vernon Hills, IL. | Medical Specialties | Director/Board Member Director/Board Member | |
Canyon Holdings (Cayman) LP
 Canyon Holdings (Cayman) LP Investment ManagersFinance Canyon Holdings (Cayman) LP operates as a pooled investment fund. The company was incorporated in 2014 and is headquartered in Chicago, IL. | Investment Managers | Director/Board Member Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Devicor Medical Products, Inc.
 Devicor Medical Products, Inc. Financial ConglomeratesFinance Devicor Medical Products, Inc. engages in acquiring medical device companies and products. Its products include mommotome revolve, elite, tissue markers, neoprene, specimen radiograph, mammo test and stereo solutions. The company was founded in 2008 and is headquartered in Cincinnati, OH. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
XIFIN, Inc.
 XIFIN, Inc. Packaged SoftwareTechnology Services XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by L?le White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Chairman | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO | |
CBR Systems, Inc.
 CBR Systems, Inc. Medical/Nursing ServicesHealth Services CBR Systems, Inc. engages in the provision of newborn stem cell company. Its clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today. The company was founded by Thomas E. Moore, Jesse O. Kramer, Wendy K. Grant, Paul R. Billings and Stephen M. Grant in 1992 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| University of Pennsylvania | College/University | Graduate Degree Graduate Degree | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Founder | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mosaic Biomedicals SL
 Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Mosaic Biomedicals SL develops personalized cancer treatments. It is engaged in the realization and development of scientific and technical research projects in the field of oncological and tumor diseases. The company was founded by Joan Seoane, Judit Anido Folgueira and José Baselga on April 19, 2013 and is headquartered in Barcelona, Spain. | Hospital/Nursing Management | Founder | |
| Emory University School of Law | College/University | Graduate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Irlanda | 3 |
| Italia | 2 |
| Spagna | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 8 |
| Technology Services | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 215 |
| Corporate Officer/Principal | 77 |
| Independent Dir/Board Member | 62 |
| Founder | 32 |
| Chief Tech/Sci/R&D Officer | 27 |
Contatti più connessi
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Dean Mihas | 35 |
| Alan Colowick | 30 |
| Ron Hunt | 29 |
| José Baselga | 27 |
| Mark Chin | 25 |
| Benjamin Daverman | 21 |
| Patrick Baeuerle | 19 |
| Scott Myers | 18 |
| Joanne Viney | 18 |
| Georgia Erbez | 18 |
| Julia Eastland | 16 |
| Lauren Silvernail | 14 |
| Sandra Horning | 14 |
| Natalie Sacks | 13 |
- Borsa valori
- Insiders
- Joseph Bailes
- Connessioni Società
